Unidad de Investigación Epidemiológica y en Servicios de Salud, Instituto Mexicano del Seguro Social, Cuernavaca, Morelos, Mexico.
UCLA Department of Health Policy and Management and Kaiser Permanente Center for Health Equity, Fielding School of Public Health, Los Angeles, CA, USA.
Int J Public Health. 2019 Apr;64(3):323-332. doi: 10.1007/s00038-018-1176-5. Epub 2018 Dec 1.
To compare the knowledge, beliefs, and practices regarding HPV vaccination among mothers of vaccine-eligible girls in Mexico and the USA.
Similar samples of Mexican mothers with vaccine-eligible daughters were surveyed at two clinics in Cuernavaca, Morelos, from July to October 2012 (n = 200) and at two clinics in Oxnard, California, from August to November 2013 (n = 200).
Although mothers in the USA had less knowledge and more negative attitudes toward the vaccine than their counterparts in Mexico, vaccine uptake rates were higher in the USA (49% vs. 40%). US mothers were more likely to have discussed and been offered the HPV vaccine by a clinician than mothers in Mexico. In multivariate analyses, having been offered the HPV vaccine was the most important predictor of vaccine uptake.
Our results suggest that healthcare access or other system, clinic, or provider factors are the main drivers of vaccine receipt in this binational sample of Mexican mothers. Interventions and programs that encourage clinicians to offer the HPV vaccine should be developed to increase vaccine uptake in both countries.
比较墨西哥和美国有资格接种 HPV 疫苗的女孩的母亲在 HPV 疫苗接种知识、信念和实践方面的差异。
2012 年 7 月至 10 月,在墨西哥莫雷洛斯州库埃纳瓦卡的两家诊所(n=200)和 2013 年 8 月至 11 月在加利福尼亚州奥克斯纳德的两家诊所(n=200),对具有资格接种 HPV 疫苗的女儿的墨西哥母亲进行了相似的抽样调查。
尽管美国母亲的疫苗知识和对疫苗的负面态度不及墨西哥母亲,但美国的疫苗接种率却更高(49%对 40%)。与墨西哥的母亲相比,美国的母亲更有可能与临床医生讨论过 HPV 疫苗,并且更有可能被提供 HPV 疫苗。在多变量分析中,被提供 HPV 疫苗是疫苗接种的最重要预测因素。
我们的研究结果表明,在这个来自墨西哥的跨国母亲样本中,医疗保健的可及性或其他系统、诊所或提供者因素是疫苗接种的主要驱动因素。应制定鼓励临床医生提供 HPV 疫苗的干预措施和项目,以增加两国的疫苗接种率。